Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1617 (ENSG00000286113) is a human gene encoding a long non-coding RNA transcript classified as a lincRNA. These molecules are longer than 200 nucleotides and are distinguished by their transcription from regions of the genome not overlapping protein-coding genes. lincRNAs have been widely implicated in regulation of gene expression, chromatin structure modification, and cellular processes, but the biological role of this specific RNA is currently uncharacterized in the literature. While lincRNAs as a group participate in disease pathways and cellular regulation, individual functional and clinical data for 'long intergenic non-protein coding RNA 1617' are lacking, and it is not considered a typical therapeutic target or biomarker at present.
None known; lincRNAs do not have established mechanisms of action for therapeutic drugs, but may act by: Recruiting epigenetic modifiers (general class); Competing for protein binding; Precursor for small RNAs (miRNAs); This is not established for ENSG00000286113 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1617 (ENSG00000286113).